Revenue
$2.3B
▲ 35.9% YoY
Net Income
-$208.2M
▼ 9.3% YoY
EPS
$-1.52
▲ 0.7% YoY
Cash
$1.1B
▲ 13.8% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Vest | Mar 16, 2026 | 50.0K | $9.59 | $480K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 16, 2026 | 100 | $190.07 | $19K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 16, 2026 | 300 | $190.68 | $57K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 16, 2026 | 900 | $192.43 | $173K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 16, 2026 | 2.3K | $194.17 | $447K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 16, 2026 | 4.9K | $195.42 | $953K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 16, 2026 | 24.8K | $196.23 | $4.87M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 16, 2026 | 16.5K | $197.22 | $3.25M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 16, 2026 | 254 | $198.02 | $50K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Vest | Mar 13, 2026 | 75.0K | $9.59 | $719K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 13, 2026 | 17.0K | $187.63 | $3.20M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 13, 2026 | 21.5K | $188.54 | $4.05M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 13, 2026 | 21.5K | $189.50 | $4.08M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 13, 2026 | 13.9K | $190.46 | $2.64M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 13, 2026 | 1.1K | $191.22 | $210K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Vest | Mar 12, 2026 | 75.0K | $9.59 | $719K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 12, 2026 | 8.1K | $186.75 | $1.51M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 12, 2026 | 5.8K | $187.52 | $1.09M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 12, 2026 | 6.5K | $188.52 | $1.22M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 12, 2026 | 2.9K | $189.64 | $547K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 12, 2026 | 22.1K | $190.53 | $4.20M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 12, 2026 | 9.9K | $191.55 | $1.90M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 12, 2026 | 8.6K | $192.79 | $1.65M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 12, 2026 | 7.0K | $193.58 | $1.36M | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 12, 2026 | 4.1K | $194.57 | $794K | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sell | Mar 12, 2026 | 100 | $195.32 | $20K | Form 4 ↗ |
Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sell | Mar 10, 2026 | 785 | $204.13 | $160K | Form 4 ↗ |
Chapman Steven Leonard CEO AND PRESIDENT | Sell | Mar 10, 2026 | 5.6K | $204.13 | $1.15M | Form 4 ↗ |
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sell | Mar 10, 2026 | 1.7K | $204.13 | $356K | Form 4 ↗ |
Sheena Jonathan | Sell | Mar 10, 2026 | 127 | $204.13 | $26K | Form 4 ↗ |
Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sell | Mar 10, 2026 | 707 | $204.13 | $144K | Form 4 ↗ |
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sell | Mar 10, 2026 | 915 | $204.13 | $187K | Form 4 ↗ |
Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Grant | Mar 9, 2026 | 2.0K | - | - | Form 4 ↗ |
Chapman Steven Leonard CEO AND PRESIDENT | Grant | Mar 9, 2026 | 5.6K | - | - | Form 4 ↗ |
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Grant | Mar 9, 2026 | 1.7K | - | - | Form 4 ↗ |
Sheena Jonathan | Grant | Mar 9, 2026 | 258 | - | - | Form 4 ↗ |
Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant | Mar 9, 2026 | 1.8K | - | - | Form 4 ↗ |
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant | Mar 9, 2026 | 1.8K | - | - | Form 4 ↗ |
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Vest | Mar 6, 2026 | 5.6K | $19.68 | $110K | Form 4 ↗ |
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sell | Mar 6, 2026 | 400 | $193.73 | $77K | Form 4 ↗ |
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sell | Mar 6, 2026 | 2.9K | $194.77 | $565K | Form 4 ↗ |
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sell | Mar 6, 2026 | 1.6K | $195.80 | $313K | Form 4 ↗ |
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sell | Mar 6, 2026 | 1.5K | $196.94 | $295K | Form 4 ↗ |
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sell | Mar 6, 2026 | 2.0K | $198.04 | $396K | Form 4 ↗ |
Sheena Jonathan | Sell | Mar 2, 2026 | 470 | $198.50 | $93K | Form 4 ↗ |
Sheena Jonathan | Sell | Mar 2, 2026 | 2.4K | $200.42 | $481K | Form 4 ↗ |
Sheena Jonathan | Sell | Mar 2, 2026 | 100 | $201.20 | $20K | Form 4 ↗ |
Sheena Jonathan | Sell | Mar 2, 2026 | 100 | $202.85 | $20K | Form 4 ↗ |
Chapman Steven Leonard CEO AND PRESIDENT | Sell | Mar 2, 2026 | 1.1K | $199.17 | $223K | Form 4 ↗ |
Chapman Steven Leonard CEO AND PRESIDENT | Sell | Mar 2, 2026 | 2.5K | $200.24 | $493K | Form 4 ↗ |
Chapman Steven Leonard CEO AND PRESIDENT | Sell | Mar 2, 2026 | 365 | $201.18 | $73K | Form 4 ↗ |
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Vest | Mar 2, 2026 | 5.1K | $9.59 | $49K | Form 4 ↗ |
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sell | Mar 2, 2026 | 931 | $198.83 | $185K | Form 4 ↗ |
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sell | Mar 2, 2026 | 1.6K | $200.11 | $319K | Form 4 ↗ |
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sell | Mar 2, 2026 | 475 | $200.97 | $95K | Form 4 ↗ |
Sheena Jonathan | Grant | Feb 27, 2026 | 2.1K | - | - | Form 4 ↗ |
Chapman Steven Leonard CEO AND PRESIDENT | Grant | Feb 27, 2026 | 37.4K | - | - | Form 4 ↗ |
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant | Feb 27, 2026 | 10.1K | - | - | Form 4 ↗ |
Rabinowitz Matthew EXECUTIVE CHAIRMAN | Grant | Feb 27, 2026 | 29.9K | - | - | Form 4 ↗ |